Posted in | News

CertusView Launches New Licensing Program for Microtrenching Construction Technology

CertusView Technologies, LLC announced today that it has launched a new licensing program for its innovative patented "Microtrenching" construction technology through its affiliate, CertusView Solutions, LLC. U.S. Patent No. 8,480,332 (issued on July 9, 2013).

Microtrenching is a minimally invasive technology which enhances the ability to place fiber optic cable quickly and cost effectively in challenging construction environments including existing roadway beds and dense urban areas. CertusView's Microtrenching process includes:

  • Cutting a narrow trench in the existing surface to create a void;
  • Evacuating debris;
  • Laying cable;
  • Flowing a non-shrinking composition into the void; and
  • Applying a topping material.

The patented process involves making a narrow cut in the existing surface and then removing the debris from the trench at the same time using a specially designed vacuum system. Fiber conduit is then placed in the trench with a backfill of custom flowable material.

This new method:

  • Limits damage to existing facilities by using a narrow shallow trench;
  • Minimizes disruption of existing traffic patterns, as vehicles can traverse the trench; and
  • Permits thousands of feet of cable to be placed in one day by using a tractor with a saw and a vacuum truck.

CertusView licenses patented equipment, hardware and software solutions to the specialty construction industry. CertusView's technology helps licensees to deliver high quality value added services to their utility customers. To learn more about CertusView, visit www.certusview.com.

Source: http://certusview.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.